Suchergebnisse - "Acampa, Maurizio"

PubPharm (162)

91

Double ophthalmic arteries arising from the internal carotid artery: a case report of a hidden second ophthalmic artery

enthalten in: Surgical and radiologic anatomy / Englische Ausgabe | 2016

von Bracco, S. | Gennari, P. | Vallone, I. | +4

92

Double ophthalmic arteries arising from the internal carotid artery: a case report of a hidden second ophthalmic artery

enthalten in: Surgical and radiologic anatomy | 2016

von Bracco, S. | Gennari, P. | Vallone, I. | +4

93

Spotlight on sirukumab for the treatment of rheumatoid arthritis : the evidence to date

enthalten in: Drug design, development and therapy | 2016

von Lazzerini, P. | Capecchi, P. | Guidelli, G. | +3

94

Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis

enthalten in: Frontiers in cardiovascular medicine | 2016

von Lazzerini, P. | Capecchi, P. | Bertolozzi, I. | +10

95

Carnitine and ventricular repolarization: A complex link?

enthalten in: Heart rhythm | 2016

von Acampa, M. | Lazzerini, P.

96

To the Editor- Carnitine and ventricular repolarization: a complex link?

enthalten in: Heart rhythm | 2016

von Acampa, M. | Lazzerini, P.

97

Letter by Acampa et al Regarding Article, “Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection”

enthalten in: Stroke | 2016

von Acampa, M. | Lazzerini, P. | Martini, G.

98

Anticoagulation in atrial fibrillation after intracranial hemorrhage: Could the hemorrhage location influence the outcome?

enthalten in: Heart rhythm | 2016

von Acampa, M. | Guideri, F. | Martini, G.

99

Letter by Acampa et al Regarding Article, “Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection”

enthalten in: Stroke | 2016

von Acampa, M. | Lazzerini, P. | Martini, G.

100

Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis : tocilizumab reduces corrected QT interval by controlling systemic inflammation

enthalten in: Arthritis care & research | 2015

von Lazzerini, P. | Acampa, M. | Capecchi, P. | +7